S. 1367 · 117th Congress
United States Pharmaceutical Supply Chain Review Act
- Stage
- In committee
- Sponsor
- Elizabeth Warren
- Introduced
- 2021-04-26
- Latest action
- 2021-04-26 · Introduced in Senate
Summary
United States Pharmaceutical Supply Chain Review Act
This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.